ELPA
Desconocido
LIVERAIM: A Biomarker Based Platform for Early Diagnosis of Chronic Liver Disease to Enable Personalized Thera...
EUROPEAN LIVER PATIENTS ASSOCIATION
participó en un
HORIZON EUROPE:
HORIZON-JU-IHI-2022-03-single-stage
Liver cirrhosis and liver cancer are common and responsible for high morbidity, impaired quality of life, major costs for healthcare systems...
2023-11-27 - 2030-02-28 | Financiado
2023-11-27 - 2030-02-28 | Financiado
LIVERATION: Unravelling the impact of Radiofrequency in liver surgery the key to decrease local recurrence?
EUROPEAN LIVER PATIENTS ASSOCIATION
participó en un
HORIZON EUROPE:
HORIZON-MISS-2022-CANCER-01
Colorectal cancer (CRC) ranks fourth in cancer deaths worldwide. Between 20% and 30% of patients with advanced CRC have liver metastases (CR...
2023-05-08 - 2028-05-31 | Financiado
2023-05-08 - 2028-05-31 | Financiado
A-TANGO: NOVEL TREATMENT OF ACUTE ON CHRONIC LIVER FAILURE USING SYNERGISTIC ACTION OF G CSF AND TAK 242
EUROPEAN LIVER PATIENTS ASSOCIATION
participó en un
H2020:
H2020-SC1-BHC-2018-2020
In Europe, about 30,000 people die every year from alcohol related cirrhosis, a form of chronic, non- communicable disease. The patients tha...
2021-01-18 - 2026-02-28 | Financiado
2021-01-18 - 2026-02-28 | Financiado
LiverScreen: Screening for liver fibrosis population based study across European countries
EUROPEAN LIVER PATIENTS ASSOCIATION
participó en un
H2020:
H2020-SC1-BHC-2018-2020
Liver cirrhosis is a very common and severe chronic disease, responsible for high morbidity, impaired quality of life, major healthcare cost...
2019-12-12 - 2025-06-30 | Financiado
2019-12-12 - 2025-06-30 | Financiado
DECISION: DECOMPENSATED CIRRHOSIS IDENTIFICATION OF NEW COMBINATORIAL THERAPIES BASED ON SYSTEMS APPROACHES
EUROPEAN LIVER PATIENTS ASSOCIATION
participó en un
H2020:
H2020-SC1-BHC-2018-2020
In 2013, cirrhosis was responsible for 1.2 million deaths worldwide. This mortality is mainly due to cirrhosis decompensation, i.e. developm...
2019-12-05 - 2025-09-30 | Financiado
2019-12-05 - 2025-09-30 | Financiado
IP-cure-B: Immune profiling to guide host directed interventions to cure HBV infections
EUROPEAN LIVER PATIENTS ASSOCIATION
participó en un
H2020:
H2020-SC1-BHC-2018-2020
The objective of the project is to develop novel curative concepts for chronic hepatitis B (CHB). Specific aims will be to: 1) improve the r...
2019-12-05 - 2024-12-31 | Financiado
2019-12-05 - 2024-12-31 | Financiado
MICROB-PREDICT: MICROBiome based biomarkers to PREDICT decompensation of liver cirrhosis and treatment response
EUROPEAN LIVER PATIENTS ASSOCIATION
participó en un
H2020:
H2020-SC1-BHC-2018-2020
Decompensation of liver cirrhosis and progression towards acute-on-chronic liver failure (ACLF) causes 1.2 million deaths/year. Microbiome i...
2018-12-03 - 2025-03-31 | Financiado
2018-12-03 - 2025-03-31 | Financiado
LIVERHOPE: SIMVASTATIN AND RIFAXIMIN AS NEW THERAPY FOR PATIENTS WITH DECOMPENSATED CIRRHOSIS
EUROPEAN LIVER PATIENTS ASSOCIATION
participó en un
H2020:
H2020-SC1-2016-2017
Liver cirrhosis is a very common chronic disease and one of the leading causes of death in European. Moreover, cirrhosis has a marked impact...
2016-12-09 - 2023-02-28 | Financiado
2016-12-09 - 2023-02-28 | Financiado
* No se disponen de datos de la empresa actual.